Therapeutics
Search By Attributes
Search Results
| Name | Synonyms | FDA Status | Company | Target Type | Therapy Type | Approved For |
|---|---|---|---|---|---|---|
| AQW051 | Alpha-7 nicotinic acetylcholine receptor agonist | Alzheimer's Disease (Inactive), Parkinson's Disease (Phase 2), Schizophrenia (Phase 2) | Novartis Pharmaceuticals Corporation | Cholinergic System | Small Molecule | |
| BPN14770 | Alzheimer's Disease (Phase 2) | Shionogi Pharma, Tetra Therapeutics | Cholinergic System, Other | Small Molecule | ||
| Deep Brain Stimulation-nucleus basalis of Meynert | DBS-nbM | Alzheimer's Disease (Phase 2) | Cholinergic System, Other | Procedural Intervention | ||
| Ladostigil | Ladostigil hemitartrate, TV3326 |
Mild Cognitive Impairment (Phase 2), Alzheimer's Disease (Discontinued) | Avraham Pharmaceuticals Ltd | Cholinergic System | Small Molecule | |
| MK-1167 | Alzheimer's Disease (Phase 2) | Merck, Neuphoria Therapeutics | Cholinergic System | Small Molecule | ||
| NA-831 | Traneurocin | Alzheimer's Disease (Phase 2) | Biomed Industries, NeuroActiva™ Inc. | Cholinergic System | Small Molecule |